ClariTrial — AI Clinical Trial Intelligence

Kaletra soft-gel capsules switched to Kaletra tabletsMOS-HIV Health and Medication Satisfaction Survey, Global Conditioning Improvement and Therapy Preference Questionnaire

AIDS Arms Inc.120 participants1 site · United States

CT.gov Full analysis →

NCT04140461

UNKNOWN

AmB Dose for Cryptococcal Meningitis

Phase 3Cryptococcal MeningitisHIV Infections

Amphotericin BFlucytosine

Shanghai Public Health Clinical Center40 participants1 site · ChinaCompletes Mar 2022

CT.gov Full analysis →

NCT04772469

Completed

Results posted

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

N/AHuman Immunodeficiency VirusAcquired Immunodeficiency SyndromeHIV Infections

Provision of multiple self-testsSmall monetary incentivesUse of SMS/text reminders to motivate adherence to ART or PrEP

University of California, San Francisco934 participants1 site · KenyaCompletes Apr 2023

CT.gov Full analysis →

NCT00824369

Terminated

Results posted

A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1

Phase 2HIV-1

No drug will be administered

Pfizer52 participants27 sites · United States, Argentina, BrazilCompletes Jul 2013

CT.gov Full analysis →

NCT04483674

UNKNOWN

Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection

Phase 2HIV Primary Infection

50mg bictegravir/200mg emtricitabine/25mg tenofovir alafenamide

Anna Cruceta66 participants1 site · SpainCompletes Nov 2022

CT.gov Full analysis →

1–15 of 11,780

Explore/HIV Infections

Status

Phase

11,780 results for “HIV Infections”

Page 1 of 786

NCT02632474

Completed

ART Drug Dosage Adjustment in HIV-infected Population

Phase 4HIV Infections

Tenofovir(TDF)+Lamivudine(3TC)+Efavirenz(EFV)

Shanghai Public Health Clinical Center10 participants1 site · ChinaCompletes Dec 2016

CT.gov Full analysis →

NCT03748797

Completed

Effects of Supervised Exercise on Physical Health and Quality of Life Among Older HIV Adults

N/AHIV/AIDS

Moderate intensity exercise training under supervision

The Society for AIDS Care21 participants1 site · Hong KongCompletes Mar 2018

CT.gov Full analysis →

NCT00679497

Completed

A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection

Phase 1HIV Infections

MVA-BPlacebo

Juan A. Arnaiz30 participants2 sites · SpainCompletes Mar 2010

CT.gov Full analysis →

NCT01136759

Completed

Tenofovir Gel in Pregnancy and Lactation

Phase 1HIV Infections

Tenofovir 1% gelPlacebo gel

National Institute of Allergy and Infectious Diseases (NIAID)232 participants2 sites · United StatesCompletes Sep 2013

CT.gov Full analysis →

NCT00183261

Completed

Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection

Phase 2HIV Infections

MRKAd5 HIV-1 gag/pol/nefMRKAd5 HIV-1 gag/pol/nef placebo

National Institute of Allergy and Infectious Diseases (NIAID)25 participants23 sites · United States, American Samoa, AustraliaCompletes Aug 2007

CT.gov Full analysis →

NCT01844297

UNKNOWN

Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy

N/AAIDS/HIV PROBLEM

TDF+3TC+EFV

Peking Union Medical College500 participants1 site · ChinaCompletes Oct 2015

CT.gov Full analysis →

NCT02801760

Completed

Self-Consent for PrEP Perspectives

N/AHIVPrEP

University of North Carolina, Chapel Hill58 participants11 sites · United StatesCompletes Mar 2016

CT.gov Full analysis →

NCT01751620

Completed

Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care

N/AHIV Positive Youth That Are Newly Engaged in Care

Project ACCEPTHEALTH

University of North Carolina, Chapel Hill167 participants4 sites · United StatesCompletes Jun 2015

CT.gov Full analysis →

NCT01926379

Completed

ENhance Initiation and Retention in Isoniazid Preventive Therapy (IPT) Care for HIV Study (ENRICH Study)

N/AHIVTuberculosis

Combination intervention componentsIsoniazid Prevention Therapy

Columbia University338 participants10 sites · EthiopiaCompletes Feb 2016

CT.gov Full analysis →

NCT00254046

Completed

Phase 3HIV

TMC125Placebo

Tibotec Pharmaceuticals, Ireland616 participants55 sites · United States, Argentina, BrazilCompletes Feb 2007

CT.gov Full analysis →

NCT00268827

Completed

A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort

Phase 4HIV-1AIDS

Kaletra soft-gel capsules switched to Kaletra tabletsMOS-HIV Health and Medication Satisfaction Survey, Global Conditioning Improvement and Therapy Preference Questionnaire

AIDS Arms Inc.120 participants1 site · United States

CT.gov Full analysis →

NCT04140461

UNKNOWN

AmB Dose for Cryptococcal Meningitis

Phase 3Cryptococcal MeningitisHIV Infections

Amphotericin BFlucytosine

Shanghai Public Health Clinical Center40 participants1 site · ChinaCompletes Mar 2022

CT.gov Full analysis →

NCT04772469

Completed

Results posted